Journal of Community Hospital Internal Medicine Perspectives · 2017 · 11 citations · 5 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyInflammationMolecular PharmacologyAtherosclerosis PharmacotherapyDyslipidemia PharmacotherapyLipid-lowering TherapyLipoprotein MetabolismProtein BindingLdl Cholesterol LoweringLipoprotein Receptor TargetingLipoprotein ReceptorsLow-density Lipoprotein Receptor FamilyPcsk9 Inhibitor TherapyPcsk9 InhibitorsProprotein Convertase Subtilisin/kexin Type 9 InhibitionProprotein Convertases
Dear Sir,Proprotein convertase subtilisin-kexin type 9 (PCSK9) is a protease that binds to the extracellular compartment of the LDL receptor, hence, targeting the LDL receptor to the lysosomal comp...
5
Ulf Landmesser, M. John Chapman, Michel Farnier et al. · European Heart Journal · 2016 · 162 citations · Full text